|
⚲
|
| Keyboard |
| BP Neuralink LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002105309 |
| Sale | |
| Fund | Venture Capital Fund |
| Phone | 7783863262 |
| Address | 3861 West 39th Avenue Vancouver, A1 V6N 3A8 |
| Source | [EDGAR] |
| Fund AUM and Sold ($) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-11-05 (D) |
| Exemption | 506(b), 3(c), 3(c)(1) |
| Remaining | Indefinite |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Ye Chen | Executive Officer | |
| Brillant Phoenix GP Inc | Director |
| Comparable Firms | State | AUM |
|---|---|---|
|
British Columbia Investment Management Corp
✚
|
A1 | |
|
Genus Capital Management Inc
✚
|
A1 | |
|
Pacad Investment Ltd
✚
|
A1 | |
|
McLean Budden Ltd
✚
|
A1 | |
|
Dixon Mitchell Investment Counsel Inc
✚
|
A1 | |
|
Asia Pacific Associates III Ltd
✚
|
A1 | |
|
JPMorgan Asset Management Canada Inc
✚
|
A1 | |
|
PenderFund Capital Management Ltd
✚
|
A1 | |
|
HSBC Global Asset Management Canada LTD
✚
|
A1 | |
|
North Growth Management Ltd
✚
|
A1 |